Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH

NCT01350960 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: SPC5001
DRUG: Saline 0.9%
DRUG: SPC5001
DRUG: SPC5001
DRUG: SPC5001
DRUG: SPC5001

Sponsor

Santaris Pharma A/S